Back to search results

Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

Abroad (travel likely)RecruitingPHASE2

Conditions

Rectal Adenocarcinoma · Rectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Colorado Cancer Center, Aurora, Colorado, United States

    Contact: Study coordinator (Radiation Therapy Group) · RTClinicalResearch@olucdenver.onmicrosoft.com · 303-724-8822
    Contact: Principal Investigator (David Binder, MD, PhD)

  • University of Rochester Medical Center, Rochester, New York, United States

  • Oregon Health and Sciences University, Portland, Oregon, United States

Study leads

  • David Binder

    Principal Investigator

    University of Colorado, Denver

View source on ClinicalTrials.gov(opens in a new tab)